Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
BioAtla financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$2
2024-10-29
Market Capitalization
$100.8 M
2024-10-29
Revenue
$11 K
FY, 2024
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|
| Revenue | 11.0K | |||
| General and administrative expense | 28.8M | 26.0M | 21.8M | 17.7M |
| Operating expense total | 108.1M | 129.7M | 84.9M | 61.3M |
| EBIT | (108.1M) | (129.7M) | (73.9M) | (59.3M) |
| EBIT margin, % | -672209.1% | |||
| Interest income | 1.6M | 6.3M | 3.4M | 843.0K |
| Net Income | (106.5M) | (123.5M) | (69.8M) | (59.6M) |
| EPS | (2.7) | (2.6) | (1.4) | (1.0) |